Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

This might be one reason the stock is upticking -

Presented at the 2016 ACR/ARHP Annual Meeting, November 13, 2016, Washington, DC

Discussion/Conclusions

•M923 was shown to be bioequivalent on all of the primary endpoints:


Ratio of M923 to EU Humira was 99.39 (90% CI 94.25-104.81) and to US Humira was 102.58 (90% CI 97.31 to 108.14).
– AUC0-inf ratios of M923 to EU Humira was 100.90 (90% CI 93.48-108.90) and to US Humira was 104.20 (90% CI 96.47-112.54)



Safety
• The incidence, severity, and type of AEs were similar across study arms.
• There were no deaths and no AEs leading to early withdrawal


Read more -

http://www.momentapharma.com/docs/ACR-2016-84x38-poster-WEB2.pdf